论文部分内容阅读
2013年，美国成立了用药安全总监协会，强调用药安全总监（MSO）为医疗保健团队的组成部分。此后，北美和欧洲部分国家通过相关组织或机构颁布了系列用药安全指南和方案，建立了较为规范的MSO工作模式、内容和流程。MSO发挥了药物安全领导者、药物安全专家、药物安全方案实践者、药物安全研究者和药物安全教育者的作用。借鉴国外MSO模式，我院组成了以药剂科主任和临床药师为成员的具有MSO相似作用的团队，负责全院的用药安全工作，该团队开展了药物不良反应（ADR）监测工作，成为北京市药品监督管理局药物警戒工作站成员，进行了多学科的药物安全研究，参与了北京市ADR监测中心数据分析，改进了我院药物应急启动预案等。我院用药安全的工作模式为事前预警、实时跟踪和事后反馈。“,”Medication Safety Officer Society was established in America in 2013 to emphasize that the Medication Safety Officer (MSO) was an integral part of the healthcare team. After that, some countries in North America and European promulgated a series of drug safety guidelines and protocols through the relevant organizations or agencies, thus to establish the normative work pattern, content, and process of MSO. The MSO plays the role of medication safety leaders, medication safety experts, medication safety program practitioners, medication safety researchers, and medication safety educators. Based on the international MSO mode, our hospital has built up a team consisted of the pharmacy department′s director and clinical pharmacists, which has similar functions in MSO, to be responsible for medication safety of the whole hospital. The team has become the member of Drug Alert Workstation of Beijing Drug Administration. They participate in multidisciplinary drug safety research, analyze the data of Beijing ADR Monitoring Centre, and have improved the drug emergency plan in our hospital. The work mode for drug safety in our hospital include pre-warning, real-time tracking, and post-feedback.